Interim results from the EQUATE Study: Preliminary safety and efficacy of itolizumab, a novel targeted anti-CD6 therapy, in newly diagnosed severe acute graft-versus-host disease

John Koreth, et. al., 2021

European Hematology Association (EHA) Virtual Congress 2021

An Assay to Monitor the Engagement and Modulation of CD6 on T cells as a Clinical Biomarker of Treatment with Itolizumab

Angelina Bisconte, et. al., 2021

American Association of Immunologists (AAI) Annual Meeting 2021

Preliminary safety and efficacy of itolizumab, a novel targeted anti-cd6 therapy, in newly diagnosed severe acute graft-versus-host disease: interim results from the equate study

John Koreth, et. al., 2021

European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting 2021

Early reconstitution of cd6+ t cells after hematopoietic cell transplantation identifies a suitable target for acute graft-versus-host disease treatment using anti-cd6 monoclonal antibody itolizumab

Benedetta Rambaldi et. al., 2021

European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting 2021

Preliminary Safety and Efficacy of Itolizumab, A Novel Targeted Anti-CD6 Therapy, in Newly Diagnosed Severe Acute Graft-Versus-Host Disease: Interim Results from Equate Study

John Koreth et. al., 2021

TCT Meetings Digital Experience 2021

Impact of Itolizumab on the Expression of CD6 and the Function of Effector T Cells

Jeanette Ampudia et. al., 2020

American Society of Hematology Annual Meeting December 2020

Early Reconstitution of CD6+ T Cells after Hematopoietic Cell Transplantation Identifies a Suitable Target for Acute Graft Versus Host Disease Treatment Using Anti-CD6 Monoclonal Antibody Itolizumab

Benedetta Rambaldi et. al., 2020

American Society of Hematology Annual Meeting December 2020

Targeting the CD6-ALCAM Pathway to Prevent and Treat Graft vs Host Disease

Cherie Ng et. al., 2020

Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy & the Center for International Blood & Marrow Transplant Research February 2020